PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding PolyPid Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 2.89M | 2.83M | −58.1K (−2.0%) |
| Value | $10.2M | $9.45M | −$757.5K (−7.4%) |
New holders (4)
Institutions that held PolyPid Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 21,773 | $72.6K | 0.00% |
| Goldman Sachs Group Inc | 14,292 | $47.7K | 0.00% |
| UBS Group AG | 1,043 | $3.48K | 0.00% |
| JPMorgan Chase & Co | 435 | $1.45K | 0.00% |
Sold out (3)
Institutions that held PolyPid Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| ADAR1 Capital Management, LLC | 103,950 | $366.9K |
| Citadel Advisors LLC | 13,151 | $46.4K |
| Raymond James Financial Inc | 65 | $229 |